- Home
- NYT vs CHE Comparison
NYT vs CHE Comparison
Compare NYT & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYT
- CHE
- Stock Information
- Founded
- NYT 1851
- CHE 1970
- Country
- NYT United States
- CHE United States
- Employees
- NYT N/A
- CHE N/A
- Industry
- NYT Newspapers/Magazines
- CHE Medical/Nursing Services
- Sector
- NYT Consumer Discretionary
- CHE Health Care
- Exchange
- NYT Nasdaq
- CHE Nasdaq
- Market Cap
- NYT 9.1B
- CHE 8.7B
- IPO Year
- NYT N/A
- CHE N/A
- Fundamental
- Price
- NYT $52.99
- CHE $572.59
- Analyst Decision
- NYT Buy
- CHE Buy
- Analyst Count
- NYT 5
- CHE 2
- Target Price
- NYT $50.60
- CHE $673.50
- AVG Volume (30 Days)
- NYT 720.4K
- CHE 61.9K
- Earning Date
- NYT 08-07-2024
- CHE 10-23-2024
- Dividend Yield
- NYT 0.98%
- CHE 0.35%
- EPS Growth
- NYT 52.50
- CHE 31.50
- EPS
- NYT 1.62
- CHE 19.72
- Revenue
- NYT $2,467,072,000.00
- CHE $2,335,557,000.00
- Revenue This Year
- NYT $8.54
- CHE $8.90
- Revenue Next Year
- NYT $6.68
- CHE $7.70
- P/E Ratio
- NYT $32.73
- CHE $28.98
- Revenue Growth
- NYT 5.50
- CHE 6.79
- 52 Week Low
- NYT $39.73
- CHE $492.84
- 52 Week High
- NYT $56.49
- CHE $654.62
- Technical
- Relative Strength Index (RSI)
- NYT 42.51
- CHE 50.04
- Support Level
- NYT $53.47
- CHE $570.31
- Resistance Level
- NYT $55.60
- CHE $590.00
- Average True Range (ATR)
- NYT 0.85
- CHE 8.34
- MACD
- NYT -0.25
- CHE -0.88
- Stochastic Oscillator
- NYT 6.45
- CHE 24.94
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the major source of revenue for both segments is subscription.
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.